Creating patient- and site-centric solutions for a challenging antibiotic study
A pharmaceutical company partnered with Fortrea to support their Phase 1b pharmacokinetic clinical trial of a new antibiotic candidate for life-threatening nosocomial infections, including drug-resistant infections.
Download Case Study